Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ebata, Takahiro
53  Ergebnisse:
Personensuche X
?
1

Clinical features and impact of p53 status on sporadic mism..:

Kato, Mayumi Kobayashi ; Fujii, Erisa ; Asami, Yuka...
Cancer Science.  115 (2024)  5 - p. 1646-1655 , 2024
Link: https://doi.org/10.1111/..
 
?
2

HSD17B4 methylation enhances glucose dependence of BT-474 b..:

Arai, Nobuaki ; Hattori, Naoko ; Yamashita, Satoshi...
Breast Cancer Research and Treatment.  201 (2023)  2 - p. 317-328 , 2023
Link: https://doi.org/10.1007/..
 
?
3

DNA methylation marker to estimate ovarian cancer cell frac..:

Ebata, Takahiro ; Yamashita, Satoshi ; Takeshima, Hideyuki...
Medical Oncology.  39 (2022)  5 - p. , 2022
Link: https://doi.org/10.1007/..
 
?
4

DNA methylation of the immediate upstream region of BRCA1 m..:

Ebata, Takahiro ; Yamashita, Satoshi ; Takeshima, Hideyuki...
Gynecologic Oncology.  167 (2022)  3 - p. 513-518 , 2022
Link: https://doi.org/10.1016/..
 
?
5

A feasibility study of lenvatinib plus pembrolizumab in Jap..:

Kitano, Shigehisa ; Fujiwara, Yutaka ; Shimizu, Toshio...
Cancer Chemotherapy and Pharmacology.  90 (2022)  6 - p. 523-529 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Risk factors for skeletal-related events in non-small cell ..:

Saito, Go ; Ebata, Takahiro ; Ishiwata, Tsukasa...
Supportive Care in Cancer.  29 (2021)  7 - p. 4081-4088 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Dose exploration results from Phase 1 study of cemiplimab, ..:

Kitano, Shigehisa ; Shimizu, Toshio ; Koyama, Takafumi...
Cancer Chemotherapy and Pharmacology.  87 (2020)  1 - p. 53-64 , 2020
Link: https://doi.org/10.1007/..
 
?
8

DMPK is a New Candidate Mediator of Tumor Suppressor p53-De..:

Itoh, Katsuhiko ; Ebata, Takahiro ; Hirata, Hiroaki...
Molecules.  24 (2019)  17 - p. 3175 , 2019
Link: https://doi.org/10.3390/..
 
?
9

Improved survival among patients enrolled in oncology phase..:

Ebata, Takahiro ; Shimizu, Toshio ; Koyama, Takafumi...
Cancer Chemotherapy and Pharmacology.  85 (2019)  2 - p. 449-459 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibito..:

Ebata, Takahiro ; Shimizu, Toshio ; Fujiwara, Yutaka...
Investigational New Drugs.  38 (2019)  2 - p. 468-477 , 2019
Link: https://doi.org/10.1007/..
 
?
11

Feasibility of initial treatment in elderly patients with o..:

Bun, Seiko ; Yunokawa, Mayu ; Ebata, Takahiro...
International Journal of Clinical Oncology.  24 (2019)  9 - p. 1111-1118 , 2019
Link: https://doi.org/10.1007/..
 
?
12

Potential Activity of Amrubicin as a Salvage Therapy for Me..:

Sakaida, Emiko ; Ebata, Takahiro ; Iwasawa, Shunichiro...
Internal Medicine.  56 (2017)  5 - p. 567-570 , 2017
Link: https://doi.org/10.2169/..
 
?
13

Nivolumab-induced Acute Fibrinous and Organizing Pneumonia ..:

Ishiwata, Tsukasa ; Ebata, Takahiro ; Iwasawa, Shunichiro...
Internal Medicine.  56 (2017)  17 - p. 2311-2315 , 2017
Link: https://doi.org/10.2169/..
 
?
14

Substrate Stiffness Influences Doxorubicin-Induced p53 Acti..:

Ebata, Takahiro ; Mitsui, Yasumasa ; Sugimoto, Wataru...
BioMed Research International.  2017 (2017)  - p. 1-10 , 2017
Link: https://doi.org/10.1155/..
 
?
15

Feasibility of dose-dense paclitaxel/carboplatin therapy in..:

Bun, Seiko ; Yunokawa, Mayu ; Ebata, Takahiro...
Cancer Chemotherapy and Pharmacology.  78 (2016)  4 - p. 745-752 , 2016
Link: https://doi.org/10.1007/..
 
1-15